Lung bioavailability of generic and innovator salbutamol metered dose inhalers

Clark, D J; Gordon-Smith, J; McPhate, G; Clark, G; Lipworth, B J
March 1996
Thorax;Mar1996, Vol. 51 Issue 3, p325
Academic Journal
No abstract available.


Related Articles

  • Development of a pMDI Formulation Containing Salbutamol. Robins, E.; Williams, G.; Priolkar, S. // Indian Journal of Pharmaceutical Sciences;2007, Vol. 69 Issue 5, p724 

    The article highlights a study on the development of a pressurized metered dose inhaler (pMDI) formulation which contains salbutamol. It says that the formulation was developed so that 120 µg of salbutamol sulphate per shot would exit that valve over 200 doses. An evaluation of the stability...

  • Initial Paradoxical Serum Potassium Increase with Inhaled Salbutamol Unsafe for Treatment of...  // Kidney;Nov/Dec99, Vol. 8 Issue 6, p267 

    Evaluates the efficacy of inhaled salbutamol in lowering serum potassium levels when rapidly delivered to patients with hyperkalemia through the MDI-S metered-dose inhaler. Initial rise in serum potassium levels within the first minute after the end of salbutamol inhalation.

  • Ipratropium bromide/salbutamol.  // Reactions Weekly;12/15/2007, Issue 1182, p22 

    The article describes the case of a 39-year-old woman who developed paradoxical bronchospasm after receiving salbutamol, ipratropium bromide and salbutamol/ipratropium bromide inhalers containing chlorofluorocarbons. She was referred with refractory asthma, and she required eight to 24 puffs of...

  • Absorption Kinetics after Inhalation of Fluticasone Propionate via the Diskhaler, Diskus and Metered-Dose Inhaler in Healthy Volunteers. Brindley, C.; Falcoz, C.; Mackie, A.E.; Bye, A. // Clinical Pharmacokinetics;2000 Supplement, Vol. 39 Issue 6, p1 

    Objective: The aim of this analysis was to assess the rate and extent of systemic availability of inhaled fluticasone propionate (FP) from 2 dry powder systems (Diskhaler and Diskus) and a metered-dose inhaler (MDI) by deconvolution analysis. Methods: The inhalation devices were evaluated in 3...

  • Salbutamol MDIs: cost saving in paediatric ED.  // PharmacoEconomics & Outcomes News;5/29/2010, Issue 604, p3 

    The article discusses research on the cost-effectiveness of salbutamol metered dose inhalers (MDIs), which references the study "Cost Effectiveness of Metered Dose Inhalers Versus Nebulisers in the Treatment of Asthma in the Pediatric Emergency Department," by Q. H. Doan et al.

  • Determination of the Relative Bioavailability of Salbutamol to the Lungs Following Inhalation from Dry Powder Inhaler Formulations Containing Drug Substance Manufactured by Supercritical Fluids and Micronization. Marcel de Matas; Harold Hosker; Rahul Mukherjee // Pharmaceutical Research;Nov2007, Vol. 24 Issue 11, p2008 

    Abstract Purpose  The relative lung bioavailability of salbutamol sulfate particles produced using supercritical fluids (SEDS™) and delivered by dry powder inhaler (DPI) was compared with the performance of a conventional micronized drug DPI using the same device...

  • MDIs in the ED for kids with asthma makes cents in Canada.  // PharmacoEconomics & Outcomes News;4/30/2011, Issue 627, p8 

    The article discusses a Canadian research which reveals that the use of metered-dose inhalers (MDIs) with spacers would produce significant cost savings when used in place of wet nebulizers to deliver salbutamol to children with asthma exacerbations.

  • Salbutamol/ipratropium bromide.  // Reactions Weekly;6/9/2012, Issue 1405, p33 

    The article describes the case of two children and two adults with asthma who developed angioedema and paradoxical bronchoconstriction following administration of salbutamol/ipratropium bromide by metered-dose inhaler (MDI).

  • Comparative toxicity assessment between generic salbutamol sulphate inhaler containing hydrofluoroalkane and Ventolin Evohaler. Singho Roy, Suvas C.; Jalil, M. A.; Sultana Tithi, Nigar; Saha, Sajal K.; Zahir Raihan, Sheikh; Chanda, Utpal K.; Ghosh, Chanchal K.; Bachar, Sitesh C. // Open Journal of Preventive Medicine;Jun2013, Vol. 3 Issue 3, p275 

    Salbutamol is a short-acting ß2-adrenergic receptor agonist used for the relief of bronchospasm such as asthma and chronic obstructive pulmonary disease (COPD). It is mostly taken through an inhaler device. The comparative toxicity assessment between two salbutamol sulfate preparations...

  • Effect of Salmeterol Is independent of Previously Inhaled Salbutamol: A Clinical Controlled Study. Wilcke, J.T.R.; Iversen, E.T.; Kok-Jensen, A. // Lung;1998, Vol. 176 Issue 2, p133 

    Examines the bronchodilating effect of an inhaled long acting beta[sub 2]-agonist (salmeterol) after a high dose of an inhaled short acting beta[sub 2]-agonist (salbutamol) in asthma patients. Additive effect of combining salbutamol and salmeterol; Absence of an effect of inhaled salbutamol on...


Read the Article


Sign out of this library

Other Topics